US13463J1016
US13463J1016
CAMP4 THERAPEUTICS CORPORATION
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 236.58M EUR | 226.92M EUR | 228.99M EUR | 318.16M EUR |
Enterprise Value | 148.16M EUR | 142.89M EUR | 131.91M EUR | 210.62M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -4.66x | -- | -- | -- |
Price to Sales | 56.11x | 53.82x | 58.21x | 120.52x |
Price to Book | -- | -- | 7.41x | 6.67x |
EV/Revenue | 35.14x | 33.89x | 33.53x | 79.78x |
EV/EBITDA | -2.93x | 20.77x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -5.42% | -12.66% | -11.46% | -4.8% |